Skip to content

GI Cancers

EU Focus Meeting 2026


📍 SANA Metropolitan Hotel, R. Soeiro Pereira Gomes 2, 1600-198 Lisbon, Portugal

🗓️ September 11 - 12, 2026


uems-eaccme-logo

CME Accreditation

The GI Cancers EU Focus Meeting 2026, Lisbon, Portugal 11/09/2026 - 12/09/2026, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 10.0 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn. org/pages/applications.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

Dear Colleagues and Friends,

We are delighted to extend our warmest invitation to the GI Cancers Focus Meeting 2026, to be held on September 11 - 12, 2026.

Centered around the theme “Updating Knowledge & Clinical Practice in 2026” this meeting provides pivotal collaboration aimed at advancing GI Cancers research and patient treatment.

This meeting presents an opportunity for medical professionals to engage in the exchange of knowledge, expertise, and insights, as well as networking with leading experts. Engage in riveting presentations, participate in thought-provoking debates and roundtable discussions, and connect with peers at informal social gatherings.

 

Chairs of GI Cancers Focus Meeting 2026:

Michel-Ducreux
Gerald-Prager

Michel Ducreux
Gustave Roussy Institute, Villejuif, France


Gerald Prager
Medical University of Vienna, Austria

Agenda & Faculty

September 11, 2026 | Day 1  

09:00 AM
Registration Opens

Session I: Pancreas Cancer
Moderated by: Teresa Macarulla

10:05 AM
Systemic Treatment Options in mPDAC
Pascal Hammel
Hôpital Beaujon, Clichy, France
10:25 AM
Targeting RAS
Davide Melisi
Medical School and University Hospital,
Verona, Italy
10:45 AM
Neoadjuvant Treatment Concepts in BR- and LA-PDACs
Teresa Macarulla
University Hospital Vall d’Hebron,
Barcelona, Spain
11:05 AM
Panel Discussion
11:25 AM

Coffee Break

Session II: Neuroendocrine Tumors
Moderated by: Michel Ducreux

11:45 AM
Strategy of Treatment of NET
Marianne Pavelt
Friedrich-Alexander University of Erlangen, Germany
12:05 PM
Neuroendocrine Carcinoma Treatment
Julien Hadoux
Gustave Roussy Institute, Villejuif, France
12:25 PM
Panel Discussion
12:45 PM
Lunch Break + Faculty and Fellow Photo

Session III: Biliary Tract Cancers
Moderated by: Arndt Vogel

01:35 PM
Stratified Treatment Concepts in Metastatic CCA
Cindy Neuzillet
Institut Curie, Paris, France
01:55 PM
Emerging Targets in CCA
Arndt Vogel
Hannover Medical School, Germany
02:15 PM
Panel Discussion
02:35 PM
Coffee Break

Session IV: Hepatocellular Cancer
Moderated by: Lorenza Rimassa

02:55 PM
Potential Role of Immunotherapy in Earlier Stages
Michel Ducreux
Gustave Roussy Institute, Villejuif, France
03:15 PM
Immunotherapy Combinations in Advanced/Met HCC
Arndt Vogel
Hannover Medical School, Germany
03:35 PM
Sequential Treatment of mHCC
Lorenza Rimassa
IRCCS Humanitas Research Hospital, Milan, Italy
03:55 PM
Panel Discussion
04:15 PM
Adjourn

September 12, 2026 | Day 1  

08:00 AM
Registration Opens
08:45 AM
Coffee Break

Session V: Esophagogastric Cancer
Moderated by: Gerald Prager

09:05 AM
Perioperative Treatment Options of Gastric Cancer
Elizabeth Smyth
University of Oxford, UK
09:25 AM
How to Stratify First-Line Treatment in mGC According to the Molecular Profile
Sylvie Lorenzen
Klinikum Rechts der Isar, Technical University Munich, Germany
09:45 AM
Panel Discussion
10:05 AM
Coffee Break

Session VI: Metastatic Colorectal Cancer
Moderated by: Tanios Bekaii-Saab

10:25 AM
Plenary Presentation: Novel Treatment Approaches in mCRC
Tanios Bekaii-Saab
Mayo Clinic, Phoenix, AZ
10:45 AM
IOs in dMMR/MSS mCRC
Thierry André
Hospital Saint-Antoine, Ap-Hp Sorbonne
University, Paris, France
11:05 AM
Who Still Benefits From (m)FOLFIRINOX
Gerald Prager
Medical University of Vienna, Austria
11:25 AM
Panel Discussion
11:45 AM
Lunch Break + Faculty and Fellow Photo

Session VII: Early-Stage and Oligometastatic CRC
Moderated by: Jenny Seligmann

12:35 PM
Organ Preservation in Rectal Cancer
Andre d’Hoore
KU Leuven, Belgium
12:55 PM
IOs Neoadjuvant or Adjuvant in Early Stage Colon Cancer?
Jenny Seligmann
University of Leeds, UK
01:15 PM
ctDNA Guided Adjuvant Treatment in Resected CRC
Gunnar Folprecht
University Hospital Carl Gustav Carus, Dresden, Germany
01:35 PM
Panel Discussion
01:55 PM
Coffee Break

Session VII: Rare GI Tumors
Moderated by: Eric Van Cutsem

02:15 PM
Immunotherapy Treatment Combinations in Metastatic Anal Canal Cancers
Sheela Rao
Royal Marsden NHS Foundation Trust,
London, UK
02:35 PM
Systemic Treatment in Small Intestine Carcinoma
Thomas Aparicio
Assistance Publique, Hôpitaux de Paris (AP-HP), France
02:55 PM
Hereditary Syndromes in GI Cancer and How to Screen
Eric Van Cutsem
KU Leuven, Belgium
03:15 PM
Panel Discussion
03:35 PM
Adjourn

Alex Worthington
Project Manager

How long has Alex Worthington been in the business?

Alex Worthington has been with MD Education since 2024

About Alex Worthington

As Assistant Project Manager, I work to ensure the Smooth running of events, assisting in the search process, outreach, organization, and the maintenance of any event. Having a Diverse Career background Working around the world, I pride myself on networking and creating positive relationships seamlessly with all attendees.

Alex-Worthington 2